In a significant breakthrough for cancer immunotherapy, collaborative studies published simultaneously in Immunity & ...
First Phase 2 chemotherapy-free, lymphodepletion-free, off-the-shelf CAR-NK cell therapy plus ANKTIVA® and rituximab regimen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results